Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „presented“
Suchtreffer
Begriffe & Kennungen
Abasaglar (previously Abasria) · 4.8 · Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Eintrag öffnenAbasaglar (previously Abasria) · 4.8 · Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Eintrag öffnenAbiraterone Mylan · 4.8 · Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.
Eintrag öffnenAdenuric · 4.8 · Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Eintrag öffnenAdenuric · 4.8 · Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Eintrag öffnenAdtralza · 4.8 · Adverse reactions observed from clinical trials and post-marketing experience are presented in Table 1 by syst
Eintrag öffnenAdynovi · 4.8 · The table presented below is according to the MedDRA system organ classification (System Organ Class and Prefe
Eintrag öffnenAdynovi · 4.8 · The table presented below is according to the MedDRA system organ classification (System Organ Class and Prefe
Eintrag öffnenAfstyla · 4.8 · Tabulated list of adverse reactions The table presented below is according to the MedDRA system organ classifi
Eintrag öffnenAhzantive · 4.8 · Within each frequency grouping, adverse drug reactions are presented in order of decreasing seriousness.
Eintrag öffnenAhzantive · 4.8 · Within each frequency grouping, adverse drug reactions are presented in order of decreasing seriousness.
Eintrag öffnenAjovy · 4.8 · ADRs from clinical studies and post-marketing reports are presented according to MedDRA system organ classific
Eintrag öffnenAkeega · 4.8 · Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.
Eintrag öffnenAlecensa · 4.8 · The ADRs listed in Table 3 are presented by system organ class and frequency categories, defined using the fol
Eintrag öffnenAlli (previously Orlistat GSK) · 4.8 · Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Eintrag öffnenAlprolix · 4.8 · Table 2 presented below is according to the MedDRA system organ classification (SOC and Preferred Term Level).
Eintrag öffnenAltuvoct · 4.8 · Table 2 presented below is according to the MedDRA system organ classification (SOC and Preferred Term Level).
Eintrag öffnenAltuvoct · 4.8 · Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Eintrag öffnenApidra · 4.8 · Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness. MedDRA Ver
Eintrag öffnenAranesp · 4.8 · Data are presented separately for CRF and cancer patients reflecting the different adverse reaction profile in
Eintrag öffnen